RxDoctor Payments DataLook up a doctor →

David Neidhardt, MD

Family Medicine · Lima, OHNPI 1396797510

Payments from drug & device makers

$248,173in general payments, 2019–2025

Across 538 payments — averaging $461.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$212K
  • Shire North American Group Inc$32K
  • AbbVie$919
  • Novo Nordisk$664
  • Boehringer Ingelheim$403
  • AstraZeneca$373
  • plus $3K from 32 others

What the payments were for

  • Consulting fees$242,01398%
  • Travel & lodging$1,1580%
  • Food & beverage$4,9872%
  • Education$150%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$248,173 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$164,163
Medicare patients
482
Services billed
2,758

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin111$122,170
MounjaroTirzepatide76$88,346
TrulicityDulaglutide54$75,080
OzempicSemaglutide58$72,696
EliquisApixaban119$71,188
FarxigaDapagliflozin Propanediol26$39,717
RybelsusSemaglutide14$27,886
Repatha SureclickEvolocumab15$10,554
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$8,672
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog15$7,358
MyrbetriqMirabegron20$7,208
SynthroidLevothyroxine Sodium106$6,652
Atorvastatin Calcium477$5,035
Rosuvastatin Calcium296$3,990
Metoprolol Succinate180$3,006

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$293$163,425130 claims
Boehringer IngelheimJardiance$403$122,170111 claims
Novo NordiskOzempic, Rybelsus$664$100,58272 claims
PfizerEliquis$197$71,188119 claims
AstraZenecaFarxiga$373$39,71726 claims
GSKTrelegy Ellipta$105$8,67212 claims
Astellas Pharma US IncMyrbetriq$65$7,20820 claims
AbbVieSynthroid$919$6,652106 claims
Sanofi-aventis U.S. LLCLantus$150$2,62615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Lima

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →